Basics Eli Lilly & Co. Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products. IPO Date: January 2, 1990 Sector: Healthcare Industry: Pharma Market Cap: $670.72B Activated in VL: True Average Daily Range Avg Daily Range: $1.65 | 0.94% Avg Daily Range (30 D): $13.16 | 1.69% Avg Daily Range (90 D): $13.12 | 1.63% Institutional Daily Volume Avg Daily Volume: 4.37M Avg Daily Volume (30 D): 3.77M Avg Daily Volume (90 D): 3.23M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 28 Avg Trade Size (Sh.) (90 D): 28 Institutional Trades Total Inst.Trades: 85,472 Avg Inst. Trade: $8.75M Avg Inst. Trade (30 D): $71.06M Avg Inst. Trade (90 D): $76.81M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 15 Market Closing Trades Avg Closing Trade: $80.7M Avg Closing Trade (30 D): $350.1M Avg Closing Trade (90 D): $381.87M Avg Closing Volume: 421.3K     News Jun 7, 2025 @ 10:10 PM Billionaire Stanley Druckenmiller Has Unloaded Sha... Source: The Motley Fool Jun 5, 2025 @ 8:15 AM Should You Invest $1,000 in Eli Lilly today? Source: Adria Cimino Jun 5, 2025 @ 7:14 AM 2 Giants in Different Technical Stages: Eli Lilly ... Source: Paulo Celig Jun 4, 2025 @ 9:12 AM Prediction: Eli Lilly Will Reach a $1 Trillion Val... Source: David Jagielski Jun 2, 2025 @ 4:07 PM Healthcare Sector Setting Up for a Catch-Up Trade ... Source: Brian Gilmartin Financials   TTM Q1 2025 Q4 2024 Basic EPS $12.34 $3.07 $4.9 Diluted EPS $12.29 $3.06 $4.88 Revenue $ 49B $ 12.73B $ 13.53B Gross Profit $ 40.03B $ 10.5B $ 11.13B Net Income / Loss $ 11.11B $ 2.76B $ 4.41B Operating Income / Loss $ 13.6B $ 3.46B $ 5.04B Cost of Revenue $ 8.97B $ 2.22B $ 2.4B Net Cash Flow $ 633.1M $ -175.1M $ -100.6M PE Ratio 0.00